EXOSENS
EXOSENS is a Public Limited Company registered in France under 89539510100028, and its current status with INPI (Institut National de la Propriété Industrielle) is active. The company was incorporated on 16 March 2021 and lists its registered address as MERIGNAC, France. 2 shareholders are on record for EXOSENS, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from INPI (Institut National de la Propriété Industrielle) and was last updated on 23 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of EXOSENS
Two shareholders are currently on record for EXOSENS, held on the statuts (articles of association) and filed corporate acts, filed under the Code de commerce. The largest of these is NEUBERGER BERMAN EQUITY FUNDS-Neuberger International Equity Fund, holding 8.7% — the largest recorded stake — followed by -Price (T.Rowe) International Small-Cap Equity Trust at 4.9%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger International Equity Fund | 8.7% | INPI (Institut National de la Propriété Industrielle) | |
| -Price (T.Rowe) International Small-Cap Equity Trust | 4.9% | INPI (Institut National de la Propriété Industrielle) |
Officers
5
Directors and officers of EXOSENS
Two of the 5 officer records shown for EXOSENS are current appointments, filed with INPI (Institut National de la Propriété Industrielle). Jerome Cerisier serves as Chief Executive Officer; Brigitte Schultz serves as Administrator. The remaining 3 records shown (Larry J. Stack, Claire Valentin and 1 other) are former appointments that have since been resigned. Management authority at EXOSENS sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 22 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Group Structure
Group structure of EXOSENS
EXOSENS sits 1 level below its ultimate parent, BPIFRANCE, registered in France. 1 subsidiary is recorded beneath it, across 1 jurisdiction. The full chain up to BPIFRANCE is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by EXOSENS's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- EXOSENS INTERNATIONAL (France)
Data availability
Those 1 subsidiary spans France jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
BPIFRANCE
France
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns EXOSENS?
Two shareholders are currently on record for EXOSENS, held on the statuts (articles of association) and filed corporate acts, filed under the Code de commerce. The largest of these is NEUBERGER BERMAN EQUITY FUNDS-Neuberger International Equity Fund, holding 8.7% — the largest recorded stake — followed by -Price (T.Rowe) International Small-Cap Equity Trust at 4.9%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is EXOSENS's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for EXOSENS is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does EXOSENS have on record?
2 shareholders are shown on record for EXOSENS.
What is EXOSENS's company registration number?
EXOSENS's registration number is 89539510100028, filed with INPI (Institut National de la Propriété Industrielle) in France. Its current status on the register is active.
Is EXOSENS still an active company?
EXOSENS's status on INPI (Institut National de la Propriété Industrielle) is listed as active.
When was EXOSENS incorporated?
EXOSENS was incorporated on 16 March 2021, according to INPI (Institut National de la Propriété Industrielle).
What is EXOSENS's registered address?
The registered address on file for EXOSENS is MERIGNAC, France.
What legal structure is EXOSENS registered as?
EXOSENS is registered as a Public Limited Company in France.
Who are the officers/directors of EXOSENS?
Two of the 5 officer records shown for EXOSENS are current appointments, filed with INPI (Institut National de la Propriété Industrielle). Jerome Cerisier serves as Chief Executive Officer; Brigitte Schultz serves as Administrator. The remaining 3 records shown (Larry J. Stack, Claire Valentin and 1 other) are former appointments that have since been resigned. Management authority at EXOSENS sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does EXOSENS have a parent company or subsidiaries?
EXOSENS sits 1 level below its ultimate parent, BPIFRANCE, registered in France. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Those 1 subsidiary spans France jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to EXOSENS's ownership over time?
This profile reflects a point-in-time snapshot from INPI (Institut National de la Propriété Industrielle). Zavia's monitoring API can track changes to EXOSENS's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access EXOSENS's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including France, so records like EXOSENS's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from INPI (Institut National de la Propriété Industrielle) and was last synced on 23 September 2026.